| Ticker Details |
Merck & Co., Inc.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$376.37B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.64 | 1.04%
|
| Avg Daily Range (30 D): |
$2.08 | 1.58%
|
| Avg Daily Range (90 D): |
$1.79 | 1.45%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
10.51M |
| Avg Daily Volume (30 D): |
7.45M |
| Avg Daily Volume (90 D): |
7.45M |
| Trade Size |
| Avg Trade Size (Sh.): |
166 |
| Avg Trade Size (Sh.) (30 D): |
63 |
| Avg Trade Size (Sh.) (90 D): |
64 |
| Institutional Trades |
| Total Institutional Trades: |
176,982 |
| Avg Institutional Trade: |
$6.03M |
| Avg Institutional Trade (30 D): |
$17.9M |
| Avg Institutional Trade (90 D): |
$17.37M |
| Avg Institutional Trade Volume: |
.1M |
| Avg Institutional Trades (Per Day): |
30 |
| Market Closing Trades |
| Avg Closing Trade: |
$88.17M |
| Avg Closing Trade (30 D): |
$209.85M |
| Avg Closing Trade (90 D): |
$243.59M |
| Avg Closing Volume: |
1.16M |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$1.27
|
$-.54
|
$-1.72
|
|
Diluted EPS
|
$1.26
|
$-.54
|
$-1.72
|
|
Revenue
|
$66.57B
|
$16.61B
|
$16.29B
|
|
Gross Profit
|
$48.57B
|
$12.21B
|
$12.09B
|
|
Net Income / Loss
|
$3.17B
|
$-1337M
|
$-4243M
|
|
Operating Income / Loss
|
$5.95B
|
$-683M
|
$-3534M
|
|
Cost of Revenue
|
$18B
|
$4.4B
|
$4.2B
|
|
Net Cash Flow
|
$-1182M
|
$1.49B
|
$-9292M
|
|
PE Ratio
|
|
|
|
|
|
|